In order to investigate the biological mechanisms of the PD-1/PD-L1 axis during human tumour–lymphocyte interaction, we have established and optimised a tumour-immune co-culture system, where unsorted healthy donor-derived primary human lymphocytes were co-cultured with human cancer cell lines (Figure S1a). The gene discussed is PDCD1; the disease is neoplasm.